Viatris, Opus granted FDA label expansion for Ryzumvi in presbyopia
Viatris, Opus granted FDA label expansion for Ryzumvi in presbyopia
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Viatris, Opus granted FDA label expansion for Ryzumvi in presbyopia